PATENT CLAIM ANALYSIS

Application Number: 15874987
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "278000"]

Abstract:
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.

Claim (Index 13):
The compound of  claim 6 , or a pharmaceutically acceptable salt thereof, wherein R 2A  is \u2014OR 5 ; and R 5  is selected from the group consisting of phenyl, 1H-pyrazolyl, and pyridinyl, wherein each of the selections is substituted with 0, 1, 2, or 3 substituents each independently selected from the group consisting of \u2014CN, halogen, C 1-4  alkyl, C 3-6  cycloalkyl, C 1-4  alkoxy, C 1-4  haloalkyl, and C 1-4  haloalkoxy.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15221658', '15808242', '13215914', '14652150', '14902324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8038422916569004
- 35 USC 102 Novelty (BERT): 0.5699183820097544
- Combined Prediction Score: 0.7804499006921858
- Mean Citation Score: 367.432016
- Max Citation Score: 449.5534
- Similarity Product: 385.1272812598944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test